The Drug Administration of Vietnam, operating under the Ministry of Health, has issued an official regulatory directive addressed to provincial and municipal health departments and Truong Duong Trading Investment Joint Stock Company regarding the immediate nationwide market suspension, recall, and destruction of a specific production batch of Coop Select feminine hygiene wash. The enforcement action was executed after state authorities conducted laboratory quality control testing on field samples and determined that the commercialized units failed to satisfy mandatory quality safety benchmarks.
The precise technical specifications, non-compliant batch parameters, and administrative pharmaceutical sanctions feature:
-
Explicit Profiling of the Recalled Asset:
-
Product Name: Coop Select Feminine Hygiene Wash (150ml bottle).
-
Identification Parameters: Batch No. S2510087; Manufacturing Date: October 21, 2025; Expiration Date: October 21, 2027; Cosmetic Product Notification Receipt No. 002013/25/CBMP-HCM.
-
Market Authorized Entity: Truong Duong Trading Investment Joint Stock Company (registered address: 160 Truong Cong Dinh, Tan Binh Ward, Ho Chi Minh City).
-
Manufacturing Plant Location: Branch of Truong Duong Trading Investment Joint Stock Company (located at 110-111 Tran Van Muoi, Ba Diem Commune, Ho Chi Minh City).
-
-
Catalyst for the Statutory Sanction: The Centers for Disease Control and Prevention (CDC) of Tay Ninh Province previously initiated random quality control sampling protocols targeting retail stocks across two supermarkets, Coopmart Tan Chau and Coopmart Tay Ninh. Subsequent independent laboratory analysis conducted by the Ho Chi Minh City Institute of Drug Quality Control alongside the Tay Ninh CDC verified that the tested samples failed to conform to the statutory quality specifications defined for microbial limits.
-
Corporate Mandates and Accountability Deadlines: The Drug Administration has legally compelled Truong Duong Trading Investment Joint Stock Company to immediately distribute formal recall notices across its entire distribution network and utilizing facilities. The corporate entity is required to accept all returned stock, manage the comprehensive physical destruction of the non-compliant inventory, and submit a detailed completion audit to the regulatory agency before July 1, 2026.
-
Jurisdictional Roles of Public Health Authorities: Central regulators directed regional health departments to notify local cosmetic retail and medical establishments to immediately cease all usage or sales of the affected batch and return units to suppliers. Concurrently, the Ho Chi Minh City Department of Health is strictly tasked with supervising the physical recall and destruction process at Truong Duong and its manufacturing branch. The municipal agency must conduct a thorough audit evaluating the firm’s adherence to cosmetic manufacturing and distribution laws, penalize violations, and file its definitive report to the Drug Administration before July 15, 2026.